Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.

Overview of attention for article published in JAMA: Journal of the American Medical Association, October 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

news: 6 news outlets
blogs: 2 blogs
twitter: 34 X users

facebook: 6 Facebook pages
googleplus: 2 Google+ users

Readers on

mendeley: 121 Mendeley

So far, Altmetric has seen 37 X posts from 34 X users, with an upper bound of 635,322 followers.

Attending #ARVO2019? Visit booth 1406 to pick up a copy of "Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks’ Gestational Age: A Randomized Clinical Trial" https://t.co/g1WFQBr4C9

In a multi-center randomized trial of 638 preterm infants, myo-inositol does not reduce retinopathy of prematurity. The trial had to be stopped for safety concerns: https://t.co/tXNpSC8qtX

In a multi-center randomized trial of 638 preterm infants, myo-inositol does not reduce retinopathy of prematurity. The trial had to be stopped for safety concerns: https://t.co/jO4up56YV2

RT @SocPedResearch: Effects of Myo-inositol on Type 1 ROP in Preterm Infants <28 Weeks’ Gestational Age. https://t.co/2N9qw3xUqp

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 33 additional X posts.